A Randomized, Double-Blind, Placebo Controlled Three-Part Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of MRX 4 Administered Orally to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts, and to Evaluate Drug Interactions With Omeprazole

Trial Profile

A Randomized, Double-Blind, Placebo Controlled Three-Part Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of MRX 4 Administered Orally to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts, and to Evaluate Drug Interactions With Omeprazole

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs MRX 4 MicuRx Pharmaceuticals (Primary) ; Omeprazole
  • Indications Gram-positive infections
  • Focus Adverse reactions
  • Sponsors MicuRx Pharmaceuticals
  • Most Recent Events

    • 03 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top